Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carvedilol (Primary)
- Indications Heart failure; Pulmonary hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PAHTCH
- 05 Dec 2018 Biomarkers information updated
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Nov 2012 Planned initiation date changed from 1 Jul 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.